COVID-19 Research News

Among 6,000 children and staffers at YMCA day camps, Duke researchers documented just 19 cases of COVID-19 while community incidence spread.

A Duke Health analysis of COVID-19 cases among youngsters attending YMCA camps in six central North Carolina counties shows minimal spread of symptomatic infections among the children and the camp counselors.

Research from Duke University and UNC-Chapel Hill suggests that schools can consider returning to in-class instruction if they mitigate COVID-19 transmission on campuses, despite the level of COVID-19 cases occurring in the community, especially when students, teachers and staff consistently wear masks, wash their hands, and practice physical distancing as recommended by the Centers for Disease Control (CDC). 

Duke University has been awarded a Eugene Washington PCORI Engagement Award to study the health concerns most important to the local Black community, particularly as they relate to COVID-19.

Duke University School of Medicine Dean Mary Klotman, MD, talks with Duke infectious disease specialists, David Montefiori, MD, and Thomas Denny, MSc, MPhil about potential issues surrounding variant strains that have emerged in the COVID-19 virus.

7 global health experts from Africa, Latin America, Asia and the U.S. talk about their continents' unique issues

As the race to produce and roll out COVID-19 vaccines around the world continued to ramp up in the first month of 2021, global health experts from four continents met with DGHI to discuss vaccine equity and allocation.

Duke University School of Medicine Dean Mary E. Klotman, MD, interviews Associate Professor of OB-GYN and Vice Dean for Scientific Integrity Geeta Swamy, MD, about the safety and possible side effects of the COVID-19 vaccine.  

[video:https://youtu.be/9EtHtFpt2M0]

Duke medical and health professions students are playing a prominent role in the distribution of COVID-19 vaccines to the Duke Health community. 

More than 100 students from the School of Medicine have volunteered to assist with the administration of the vaccines at Duke vaccination sites. As of January 13, 2021, more than 18,000 vaccinations have been administered to Duke Health employees. Last week, Duke began vaccinating community members over the age of 75. 

Duke University School of Medicine Dean Mary E. Klotman, MD, talks with co-founders of Duke’s LATIN-19 initiative Viviana S. Martinez-Bianchi, MD, Associate Professor of Family Medicine and Community Health, and Gabriela Maradiaga Panayotti, MD, Assistant Professor of Pediatrics, about the impact of the COVID-19 pandemic on the Latinx community and LATIN-19’s organized efforts to advocate for needs of this community of people.

Since March, Jacob Feigal, MD, a medical instructor in the Departments of Psychiatry and Medicine, and Nicholas Turner, MD, MHSc, a medical instructor in the Department of Medicine, have been collaborating with city and county stakeholders to mitigate the impact of COVID-19 among individuals suffering from homelessness.

Dr. Susanna Naggie has some reassuring facts to share

With two vaccines being rolled out under emergency use approval from the Food and Drug Administration, health care workers and others with high risk of COVID exposure are now being vaccinated at Duke and elsewhere around the country.

We asked infectious disease specialist Dr. Susanna Naggie of the Duke University School of Medicine to answer some of the common questions the public has been raising about these vaccines.